Asia-pacific Anti Fungal Market Forecast 2017-2025
Asia Pacific antifungal agents market is expected to grow at a CAGR of 10.33% in the forecasted period of 2017-2025. The market was calculated to be $1648 million in 2016 and is expected to hit $3959 million by 2025. Poor hygiene, developing new drug resistance are some of the factors helping the market to surge ahead.
The antifungal agent market segmentation by drug types is on the basis of Echinocandins market, Azoles market, Polyenes market, Allylamines and others. It is further segmented by therapeutic indications on the basis of Aspergillosis, Dermatophytosis and Candidiasis market. It is further divided by applications on the basis of topical antifungal agents and Oral drugs market. Initiatives taken by the government in healthcare policies and programs is the major factor responsible for the growth of the antifungal agent market in Asia pacific region. Alternate treatment options and regulatory conditions are the restraints faced by the anti-fungal market.
The major market players in the antifungal market are Abbott Laboratories, Arbor PharmaceuticalsINC, Baxter, Astellas Pharma Inc, Bayer Healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson&Johnson, Kramer Laboratories, Merck Co, Novartis and Pfizer, Sanofi- Aventis, Vertex Pharmaceuticals.